PT891371E - Derivados 9-oxima-sililo da eritromicina a - Google Patents

Derivados 9-oxima-sililo da eritromicina a

Info

Publication number
PT891371E
PT891371E PT97905826T PT97905826T PT891371E PT 891371 E PT891371 E PT 891371E PT 97905826 T PT97905826 T PT 97905826T PT 97905826 T PT97905826 T PT 97905826T PT 891371 E PT891371 E PT 891371E
Authority
PT
Portugal
Prior art keywords
derivatives
erythromycin
silillus
oxym
alkylerythromycin
Prior art date
Application number
PT97905826T
Other languages
English (en)
Portuguese (pt)
Inventor
Yi-Yin Ku
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24510750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT891371(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT891371E publication Critical patent/PT891371E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97905826T 1996-04-02 1997-02-06 Derivados 9-oxima-sililo da eritromicina a PT891371E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/626,524 US5837829A (en) 1996-04-02 1996-04-02 9-oximesilyl erythromycin a derivatives

Publications (1)

Publication Number Publication Date
PT891371E true PT891371E (pt) 2004-04-30

Family

ID=24510750

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97905826T PT891371E (pt) 1996-04-02 1997-02-06 Derivados 9-oxima-sililo da eritromicina a

Country Status (10)

Country Link
US (1) US5837829A (cg-RX-API-DMAC7.html)
EP (1) EP0891371B1 (cg-RX-API-DMAC7.html)
JP (2) JP2000507574A (cg-RX-API-DMAC7.html)
AT (1) ATE256138T1 (cg-RX-API-DMAC7.html)
CA (1) CA2250771C (cg-RX-API-DMAC7.html)
DE (1) DE69726714T2 (cg-RX-API-DMAC7.html)
DK (1) DK0891371T3 (cg-RX-API-DMAC7.html)
ES (1) ES2212808T3 (cg-RX-API-DMAC7.html)
PT (1) PT891371E (cg-RX-API-DMAC7.html)
WO (1) WO1997036913A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004574A1 (en) 1996-07-29 1998-02-05 Abbott Laboratories Preparation of crystal form ii of clarithromycin
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
AU2274799A (en) * 1997-12-22 1999-07-12 Biochemie S.A. Intermediates in macrolide production
KR100283990B1 (ko) * 1998-12-29 2001-03-02 민경윤 에리스로마이신 a 유도체 및 그의 제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
GB9915745D0 (en) * 1999-07-06 1999-09-08 Biochemie Sa Organic compounds
ES2244491T3 (es) * 1999-12-16 2005-12-16 Teva Pharmaceutical Industries Ltd. Procedimiento para la preparacion de polimorfos de claritromicina y nuevo polimorfo iv.
HRP20020572A2 (en) 2000-01-11 2005-04-30 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
KR20030047873A (ko) * 2000-02-29 2003-06-18 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 및 클라리트로마이신 중간체의 제조방법, 실질적으로는 옥심이 제거된 클라리트로마이신 및이를 포함하는 약학적 조성물
ES2242668T3 (es) * 2000-03-15 2005-11-16 Hanmi Pharm. Co., Ltd. Metodo para obtener claritromicina en cristales de forma ii.
KR100367981B1 (ko) * 2000-11-23 2003-01-14 한미약품공업 주식회사 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물
US6541014B2 (en) 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
US8246996B2 (en) * 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
US20060111560A1 (en) * 2004-11-01 2006-05-25 Glenmark Pharmaceuticals Limited Process for the preparation of crystalline form II of clarithromycin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
DK2182983T3 (da) 2007-07-27 2014-07-14 Janssen Alzheimer Immunotherap Behandling af amyloidogene sygdomme med humaniserede anti-abeta antistoffer
WO2009023191A2 (en) * 2007-08-09 2009-02-19 Teva Pharmaceutical Industries Ltd. An improved process for the preparation of clarithromycin
JO3076B1 (ar) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap نظم العلاج المناعي المعتمد على حالة apoe
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) * 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법

Also Published As

Publication number Publication date
ES2212808T3 (es) 2004-08-01
WO1997036913A1 (en) 1997-10-09
JP2000507574A (ja) 2000-06-20
CA2250771C (en) 2006-05-02
EP0891371B1 (en) 2003-12-10
JP2007224035A (ja) 2007-09-06
DE69726714D1 (en) 2004-01-22
DK0891371T3 (da) 2004-04-13
ATE256138T1 (de) 2003-12-15
DE69726714T2 (de) 2004-10-07
EP0891371A1 (en) 1999-01-20
CA2250771A1 (en) 1997-10-09
US5837829A (en) 1998-11-17

Similar Documents

Publication Publication Date Title
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
ES2191982T3 (es) Derivados de 6-o-alquilo de eritronolida b.
NO176823C (no) Fremgangsmåte for fremstilling av fermentert soyasaus
FI906083A7 (fi) Foerbaettringar i cyklopeptidderivat och beroerande dessa.
AU7596587A (en) Benzimidazole derivatives
AU8304087A (en) Coumarane derivatives, their production and use
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO913745D0 (no) Fremgangsmaate for fremstilling av 1,3-benzoksazinderivater
AU6867487A (en) Benzimidazole derivatives
NO901070L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
TR23145A (tr) Diflufenican kullanan herbisidal usul
FI894792A0 (fi) Anordning och foerfarande foer maetning av elstroem i stoerda foerhaollanden.
AU7703887A (en) Tube expander
KR970702922A (ko) 독소루비신의 제조방법(Process for preparing doxorubicin)
NO901071L (no) Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater.
AU8204887A (en) Conjugate vaccine
AU7216287A (en) Benzimidazole derivatives
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
NO893713L (no) Fremgangsmaate for fremstilling av benzoksazolon-derivater.
DE59003497D1 (de) Verdoppelte Reaktivfarbstoffe.
ZA891242B (en) 24r-scymnol,and preparation and use thereof
NO894016D0 (no) Ultramild toalettsaape og fremgangsmaate for fremstilling av saapen.
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
AU6679490A (en) Dye couplers
NO890216D0 (no) Fremgangsmaate for revitalisering av forstkulturer.